Heart in Diabetes (HiD), now in its 3rd year, is a unique medical conference bringing together world-renowned clinical leaders in diabetes and cardiovascular disease. The program is designed to evaluate the state-of-the-art clinical data and research while focusing on the management of the heart and kidney in diabetes. The goal is to align cardiologists, endocrinologists, diabetologists, iridologists and nephrologists in their understanding and development of appropriate comprehensive clinical management plans for very high-risk patients.
The World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC), now in its 17th year, is a unique and exciting multidisciplinary program. The congress is the premier global meeting dedicated to diabetes, obesity, lipids, cardiovascular disease and energy balance. The program is designed to evaluate the existing clinical and basic science, understand pathophysiology, and develop appropriate comprehensive clinical management plans. The congress' intimate setting promotes a lot of personal contact between participants and the faculty wherein everyone learns from the free flow of questions and personal observations.
"CourseForDoctors.com is a platform that is dedicated to all medical doctors and allied health professionals who are looking to keep their knowledge up to date by finding the right educational sessions and getting the latest news updates in their field of practice. Our platform is open for advertising all healthcare related meetings, seminars, workshops, and conferences."
The Pharma Times provides with the latest breaking news and videos straight from the Pharma industry including in depth coverage, news, views, reviews market dynamics, research and design of this industry
CN1699.CN belongs to Hong Kong Chenyang Trading Limited Company, which was founded in 2006 which was mainly engaged in the import & export trade of International Logistics supply chain for medical device and equipment. In 2014, the company cooperated with Oracle in developing digital, social and mobile marketing platform (B2B2C) for medical devices. At present, the company is headquartered in Hong Kong with branches in the Philippines and in Guangzhou, China.